Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.48 | 0.0003 |
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0008 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |